Precise Biometrics AB Performance
| PRBCFDelisted Stock | USD 0.36 0.00 0.00% |
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Precise Biometrics are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Precise Biometrics AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental indicators, Precise Biometrics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 76.3 M | |
| Total Cashflows From Investing Activities | -30.3 M |
Precise |
Precise Biometrics Relative Risk vs. Return Landscape
If you would invest 36.00 in Precise Biometrics AB on September 25, 2025 and sell it today you would earn a total of 0.00 from holding Precise Biometrics AB or generate 0.0% return on investment over 90 days. Precise Biometrics AB is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Precise, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Precise Biometrics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Precise Biometrics' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Precise Biometrics AB, and traders can use it to determine the average amount a Precise Biometrics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| PRBCF |
Based on monthly moving average Precise Biometrics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Precise Biometrics by adding Precise Biometrics to a well-diversified portfolio.
Precise Biometrics Fundamentals Growth
Precise Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Precise Biometrics, and Precise Biometrics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Precise Pink Sheet performance.
| Return On Equity | -0.12 | |||
| Return On Asset | -0.0404 | |||
| Profit Margin | (0.15) % | |||
| Current Valuation | 17.35 M | |||
| Shares Outstanding | 46.43 M | |||
| Price To Earning | 39.30 X | |||
| Price To Book | 2.69 X | |||
| Price To Sales | 2.77 X | |||
| Revenue | 83.32 M | |||
| EBITDA | (13.13 M) | |||
| Cash And Equivalents | 10.28 M | |||
| Cash Per Share | 0.03 X | |||
| Debt To Equity | 0.33 % | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (1.49 M) | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 241.05 M | |||
| Current Asset | 107 M | |||
| Current Liabilities | 19 M | |||
About Precise Biometrics Performance
By analyzing Precise Biometrics' fundamental ratios, stakeholders can gain valuable insights into Precise Biometrics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Precise Biometrics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Precise Biometrics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Precise Biometrics AB offers identification software for the secure authentication of peoples identity in Europe, Asia, and the United States. Precise Biometrics AB was incorporated in 1997 and is headquartered in Lund, Sweden. Precise Biometrics operates under Security Protection Services classification in the United States and is traded on OTC Exchange. It employs 31 people.Things to note about Precise Biometrics performance evaluation
Checking the ongoing alerts about Precise Biometrics for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Precise Biometrics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Precise Biometrics is not yet fully synchronised with the market data | |
| Precise Biometrics has some characteristics of a very speculative penny stock | |
| Precise Biometrics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 83.32 M. Net Loss for the year was (13.45 M) with profit before overhead, payroll, taxes, and interest of 63.54 M. | |
| Precise Biometrics AB has accumulated about 10.28 M in cash with (1.49 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. | |
| Roughly 26.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Precise Biometrics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Precise Biometrics' stock is overvalued or undervalued compared to its peers.
- Examining Precise Biometrics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Precise Biometrics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Precise Biometrics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Precise Biometrics' pink sheet. These opinions can provide insight into Precise Biometrics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Precise Pink Sheet
If you are still planning to invest in Precise Biometrics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Precise Biometrics' history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |